K2M obtains FDA approval to market MESA 2 Deformity Spinal System

K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market the MESA 2 Deformity Spinal System.



from The Medical News http://ift.tt/15eAT2U